The Patent Finder

Terms ending in 2034

Irm LLC

Every in-force patent on Irm LLC's record whose computed term ends in 2034, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 9,649,359Peptides and Compositions for Treatment of Joint Damage
In force
 · High confidence
Irm LLCIn forceHigh confidence
US 10,239,927Peptides and Compositions for Treatment of Joint Damage
In force
 · Low confidence
Novartis AGIn forceLow confidence
US 10,328,126Peptides and Compositions for Treatment of Joint Damage
In force
 · High confidence
Novartis AGIn forceHigh confidence
US 10,533,042Peptides and Compositions for Treatment of Joint Damage
In force
 · Low confidence
Novartis AGIn forceLow confidence
US 11,179,442Peptides and Compositions for Treatment of Joint Damage
In force
 · High confidence
Novartis AGIn forceHigh confidence
US 9,789,203Antibody Drug Conjugates
In force
 · High confidence
Novartis AGIn forceHigh confidence
US 10,786,578Ckit Antibody Drug Conjugates
In force
 · High confidence
Novartis AGIn forceHigh confidence
US 9,301,971Peptides and Compositions for Treatment of Joint Damage
In force
 · High confidence
Irm LLC.In forceHigh confidence
US 11,111,283Peptides and Compositions for Treatment of Joint Damage
In force
 · Low confidence
Novartis AGIn forceLow confidence
US 11,370,820Peptides and Compositions for Treatment of Joint Damage
In force
 · Medium confidence
Novartis AGIn forceMedium confidence
11 more term ends in 2034 · Pro
10 of 21 patents shown. Soonest term end first, then patent number.
Pro members see all 21.
Upgrade to Pro
3 of these are in force and held by Irm LLC.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited